L
Lluís Puig
Researcher at Autonomous University of Barcelona
Publications - 510
Citations - 16811
Lluís Puig is an academic researcher from Autonomous University of Barcelona. The author has contributed to research in topics: Psoriasis & Medicine. The author has an hindex of 56, co-authored 427 publications receiving 13381 citations. Previous affiliations of Lluís Puig include Jikei University School of Medicine & Pompeu Fabra University.
Papers
More filters
Journal ArticleDOI
Extension malunion of the femoral component after retrograde nailing: no sequelae at 6 years.
Xavier Pelfort,Raúl Torres-Claramunt,Pedro Hinarejos,Joan Leal,Sergi Gil-González,Lluís Puig +5 more
TL;DR: It is found that isolated hyperextension of the femoral component of a TKA after placing a retrograde nail for a periprosthetic fracture does not seem to significantly affect the functional or radiological outcomes at ∼6-years follow-up.
Journal ArticleDOI
Iliotibial band friction syndrome after anterior cruciate ligament reconstruction using the transfix device: report of two cases and review of the literature.
TL;DR: The use of hamstrings is increasing as a treatment for anterior cruciate ligament (ACL) injuries and there are a lot of new devices and techniques that try to fix the graft without causing further injury or increased morbidity.
Journal ArticleDOI
Effect of pimecrolimus cream 1% on the long-term course of pediatric atopic dermatitis.
Kim A. Papp,Doris Staab,John Harper,Paul C. Potter,Lluís Puig,J.-P. Ortonne,Stephen Molloy,Nathalie Barbier,Carle Paul +8 more
TL;DR: The effect of pimecrolimus cream 1% (Elidel®, Novartis pharma AG, Basel, Switzerland), a nonsteroid, cell‐selective, cytokine inhibitor on the course of atopic dermatitis (AD), is investigated by changes in body surface involvement and pattern of drug use over time.
Journal ArticleDOI
Merkel cell (primary neuroendocrine) carcinoma of the skin with nodal metastasis showing rhabdomyosarcomatous differentiation
María Teresa Fernández-Figueras,Lluís Puig,Montserrat Gilaberte,María Del Carmen Gómez-Plaza,Jordi Rex,Carlos Ferrándiz,Aurelio Ariza +6 more
TL;DR: C capacity for divergent differentiation appeared late in the course of the tumor, which suggests a clonal origin for both components of the neoplasm.
Journal ArticleDOI
Biosimilars for psoriasis: preclinical analytical assessment to determine similarity.
Andrew Blauvelt,A.D. Cohen,A.D. Cohen,Lluís Puig,Ronald Vender,J. M. Van der Walt,Jashin J. Wu +6 more
TL;DR: The science behind the preclinical development of biosimilars is discussed by members of the International Psoriasis Council, and suggestions are put forth to try to ensure that future biosimilar products are produced in a high quality and standardized manner.